Iaso Therapeutics

East Lansing, MI · Founded 2018 · Privately Held (backing)

Operator of synthetic antigen-based vaccines designed to prevent and treat infectious diseases. Iaso Therapeutics is based in East Lansing, MI and was founded in 2018. Its last reported valuation was $5.3 million in Jan 2023. It has raised $1.8 million across 2 recorded rounds; the latest was a $570,000 seed round in Jan 2026.

Last reported valuation
$5.3M
Oct 2026
Priced at
—
Total raised
$1.8M
Last round
Seed Round
Jan 2026
How much has Iaso Therapeutics raised?
$1.8Macross 2 recorded rounds · Dec 2022 – Jan 2026

Most recently, Iaso Therapeutics raised $570K in its Seed Round (Jan 2026).

Free account
More of Iaso Therapeutics with a free account
  • ·Watch Iaso Therapeutics: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Iaso Therapeutics round by round

2 rounds
Jan 2026Seed Round$570KSEC filing▮
1 investors participated
Dec 2022Seed Round$438KSEC filing▮
5 investors participated

How much has Iaso Therapeutics raised?

Iaso Therapeutics has raised $1.8 million in total; 2 of its rounds are on record. The largest on record was a $570,000 seed round in Jan 2026.

Iaso Therapeutics has filed 1 Form D with the SEC, most recently in Jan 2023 ($437,850 sold to 5 investors).

Iaso Therapeutics investors

6 investors are on record for Iaso Therapeutics, including US National Science Foundation, Michigan Rise, Apjohn Group and Biosciences Research and Commercialization Center. The seed round in Jan 2026 drew 1 investor.

For fundraisers
Raising for a company like Iaso Therapeutics?

6 investors have backed Iaso Therapeutics.

See all 6 investors →

Frequently asked about Iaso Therapeutics

How much has Iaso Therapeutics raised?
Iaso Therapeutics has raised $1.8M in total across 2 recorded funding rounds.
When was Iaso Therapeutics's last funding round?
Iaso Therapeutics's most recent recorded round was Seed Round in Jan 2026, raising $570K.